Rosemary Mazanet MD, Ph.D
Internal Medicine and Oncology at the Brigham and Women’s Hospital / Harvard Dana Farber Cancer Institute
- 30+ year career as a celebrated Biotech investor, advisor, capital markets and C-suite executive at several biopharma companies including former head of clinical research at Amgen, Inc.
- As one of the first US trained clinician scientists in her field, she led multiple successful product development initiatives (4 INDs and sBLAs, one BLA, CE mark and IDE) including FDA panel presentations
- Held subsequent executive positions at NY-based firms Argenis LP and Oracle Partners LP, one of the first health-care focused hedge funds
- Chief Scientific Officer at Columbia Care, Trustee at the University of Pennsylvania Health System (her alma mater) and Chair, Executive Advisory Board for the Wharton Leonard
Independent Director
- Member of the Audit Committee
- Member of the Compensation Committee
- Chair of the Nominating and Corporate Governance Committee